STRUCTURAL changes in global
pharmaceutical manufacturing are creating fresh opportunities for major
logistics service providers, according to a study by the UK's Transport
Intelligence.
The study, Global
Pharmaceutical Logistics 2012, said mergers in the pharma sector, expiry dates
of drug patents, global manufacturing, greater regulatory intrusion and the
lack of new drugs in pipeline will make supply chains more complex and
lucrative.
Manufacturers are also
moving into emerging markets to sell and source production to counter rising
European and American costs, the report said. Even research and development and
clinical trials are being shifted to places like China and India.
The report said this would
increase demand for more sophisticated logistics services as outsourcing the
actual manufacture in developing countries takes hold, and resources in the
developed world focus more on research and development, said the report.
The increased demand in
personalised drugs and biopharmaceuticals will also result in demand for
value-added services, such as temperature-controlled transport and higher work
volumes needed to cope with the shorter shelf life of today's drugs.
"Past reluctance to
utilise logistics providers has changed as many manufacturers are partnering
with logistics providers who have proven not only their understanding of the
industry, but also have been instrumental in the introduction of specific
solutions," said the report's author, Ti analyst Cathy Roberson.
"These have included
such services as temperature-controlled containers, IT solutions to track and
monitor temperature sensitive products as well as becoming trade and compliance
consultants," she said.
Source : HKSG, 06.12.11.
Tidak ada komentar:
Posting Komentar